YAP1 and neoplasm: Treatment of osteosarcoma cells with TZDs leads to YAP phosphorylation and nuclear exclusion, with a decrease in canonical YAP target genes, suggesting that TZDs exert their tumor suppressive activity in part through a mechanism akin to activation of the Hippo pathway.